A Systematic Review and Meta-analysis of Randomized Controlled Trials on the Effects of Turmeric and Curcuminoids on Blood Lipids in Adults with Metabolic Diseases
- 18 June 2019
- journal article
- review article
- Published by Elsevier in Advances in Nutrition
- Vol. 10 (5) , 791-802
Abstract
Dyslipidemia is a global health problem and a high risk factor for atherosclerosis, which can lead to serious cardiovascular disease (CVD). Existing studies have shown inconsistent effects of turmeric and curcuminoids on blood lipids in adults. We performed this systematic review and meta-analysis to evaluate the effects of turmeric and curcuminoids on blood triglycerides (TG), total cholesterol (TC), LDL cholesterol, and HDL cholesterol. We searched the English databases of the Web of Science, PubMed, Ovid (including EMBASE and MEDLINE), Scopus, and the Cochrane Library and 2 Chinese databases, Wanfang Data and China National Knowledge Infrastructure, for randomized controlled trials (RCTs) that studied the effects of turmeric and curcuminoids on blood TG, TC, LDL cholesterol, and HDL cholesterol in subjects with metabolic diseases. With random-effects models, separate meta-analyses were conducted by using inverse-variance. The results are presented as the mean difference with 95% CIs. Evidence from 12 RCTs for TG, 14 RCTs for TC, 13 RCTs for LDL cholesterol, and 16 RCTs for HDL cholesterol showed that turmeric and curcuminoids could lower blood TG by −19.1 mg/dL (95% CI: −31.7, −6.46 mg/dL; P = 0.003), TC by −11.4 mg/dL (95% CI: −17.1, −5.74 mg/dL; P < 0.0001), and LDL cholesterol by −9.83 mg/dL (95% CI: −15.9, −3.74 mg/dL; P = 0.002), and increase HDL cholesterol by 1.9 mg/dL (95% CI: 0.31, 3.49 mg/dL; P = 0.02). In conclusion, turmeric and curcuminoids can significantly modulate blood lipids in adults with metabolic diseases. However, these findings should be interpreted cautiously because of the significant heterogeneity between included studies (I2 > 50%). There is a need for further RCTs in future.Keywords
Funding Information
- National Natural Science Foundation of China (81673928, 81473637)
This publication has 54 references indexed in Scilit:
- Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in MicePLOS ONE, 2013
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart DiseaseNutrients, 2013
- Curcumin as a Potent and Selective Inhibitor of 11β-Hydroxysteroid Dehydrogenase 1: Improving Lipid Profiles in High-Fat-Diet-Treated RatsPLOS ONE, 2013
- Curcuminoids exert glucose‐lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double‐blind, placebo‐controlled trialMolecular Nutrition & Food Research, 2012
- Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover TrialPhytotherapy Research, 2012
- Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled studySurgical Endoscopy, 2011
- Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled studyScandinavian Journal of Urology and Nephrology, 2011
- New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseasesEuropean Journal of Nutrition, 2011
- Bioavailability of Curcumin: Problems and PromisesMolecular Pharmaceutics, 2007
- Interleukin-6-deficient mice develop mature-onset obesityNature Medicine, 2002